UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000020137
Receipt No. R000023260
Official scientific title of the study Improvement of joint pain and safety by ingestion of supplement containing glucosamine: a randomized, double blind, placebo-controlled study
Date of disclosure of the study information 2015/12/09
Last modified on 2016/09/01 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Improvement of joint pain and safety by ingestion of supplement containing glucosamine: a randomized, double blind, placebo-controlled study
Title of the study (Brief title) Improvement of joint pain and safety by ingestion of supplement containing glucosamine
Region
Japan

Condition
Condition Healthy adult
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study aims to evaluate improvement of joint pain (in knee, elbow, and back), and safety by ingestion of supplement containing glucosamine consecutively on healthy adult.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 2-step test (locomotion test), subjective evaluation (J-KOOS, JKOM, HAQ, ODI) <before and after ingestion of supplement for 16 weeks>
Key secondary outcomes safety <before and after ingestion of supplement for 16 weeks>

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Intake test sample for 16 weeks
Interventions/Control_2 Intake placebo for 16 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
30 years-old <=
Age-upper limit
69 years-old >
Gender Male and Female
Key inclusion criteria Male and female between 30 and 69 years of age
Key exclusion criteria 1. Subjects with joint pain caused by gout or rheumatism
2. Subjects with surgical experience for knee or elbow
3. Subjects with a history of fracture or sprain within the past 3 months
4. Subject with a past history of diseases in heart, kidney, liver, digestive organ, blood vessels or metabolism
5. Subjects who consume food or medicinal product containing glucosamine, chondroitin or hyaluronan
6. Subjects with food allergies
7. Subjects who are pregnant or lactating
8. Subjects who are judged as unsuitable for the study by the investigator for other reasons
Target sample size 50

Research contact person
Name of lead principal investigator Masatomo Najima
Organization Japan clinical trial association
Division name N.A.
Address 8F, 5-27-3 sendagaya, shibuyaku, Tokyo
TEL 03-6457-4666
Email info@yakujihou.org

Public contact
Name of contact person Hirohisa Kojima
Organization Japan clinical trial association
Division name N.A.
Address 8F, 5-27-3 sendagaya, shibuyaku, Tokyo
TEL 03-6457-4666
Homepage URL
Email info@yakujihou.org

Sponsor
Institute Japan clinical trial association
Institute
Department

Funding Source
Organization Yawata Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 09 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 10 Month 29 Day
Anticipated trial start date
2015 Year 12 Month 09 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 12 Month 09 Day
Last modified on
2016 Year 09 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023260